RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

Abstract

RIPK4 (receptor interacting serine/threonine kinase 4) has been reported to be aberrantly expressed in several cancer types. However, its expression pattern and functions in nasopharyngeal carcinoma (NPC) have never been reported. In this study, we have shown that the expression of RIPK4 was up-regulated in NPC tissues. RIPK4 promoted the growth and anchorage-independent growth of NPC cells, and down-regulation of RIPK4 inhibited the growth of NPC cells both in the plate-based culture and on the soft agar. Moreover, RIPK4 promoted the expression of VEGF in the NPC cells and induced the tube formation of HUVEC, and Axitinib (the inhibitor for VEGF receptor) inhibited the tumorigenesis driven by RIPK4. In the molecular mechanism study, RIPK4 was found to enhance the interaction between IKKα and IKKβ, and activated NF-kB signaling. Taken together, our study demonstrated the oncogenic roles of RIPK4 in NPC and suggested that RIPK4 might be a therapeutic target.

Author supplied keywords

Cite

CITATION STYLE

APA

Gong, Y., Luo, X., Yang, J., Jiang, Q., & Liu, Z. (2018). RIPK4 promoted the tumorigenicity of nasopharyngeal carcinoma cells. Biomedicine and Pharmacotherapy, 108, 1–6. https://doi.org/10.1016/j.biopha.2018.08.147

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free